2018
RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA®
Advitech’s new project: APIsTRENDS – a collection of reports
Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US
Wound care: Nexodyn® AOS comes to fruition in Slovakia
Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)
PKU GOLIKE® comes to fruition in Italy
La farmaceutica ticinese a Madrid per la CPhI 2018
Paolo Magri nominated as President of the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT)
Rare Diseases: Expected Benefits of a Physiological Absorption of Amino Acids in PKU management. PKU GOLIKE® by APR can play a role
Progetto Talenti
Linkedin